Anthony Johnson

Anthony Johnson serves as the Chief Executive Officer and President of Kodikaz Therapeutic Solutions, Inc. since January 2019, focusing on developing cures for chronic diseases. Additionally, Johnson holds the position of Director and Chair of Corporate Governance & Nominating Committee at 22nd Century Group, Inc., and is a board member at NewYorkBIO and the Michigan Street African American Heritage Corridor Commission. Johnson has been a fellow at The Aspen Institute and serves as a partner and co-founder of Buffalo BioSciences, which specializes in bioscience technology commercialization. Previous roles include President/CEO of Empire Genomics, where Johnson supported the firm’s growth from academic spinout to revenue generation, and Business Area Manager at Invitrogen Corporation, where strategic leadership in the stem cell market was established. Johnson holds an MBA in International Strategy from Alliance Manchester Business School and a B.S. in Biology/Pre-med from Fisk University.